Case Report September 6, 2022

Cannabis-Induced Pancytopenia

; ; ; ;

Prim Care Companion CNS Disord 2022;24(5):21cr03155

  1. Gayathri BN, Rao KS. Pancytopenia: a clinico hematological study. J Lab Physicians. 2011;3(1):15–20. PubMed CrossRef
  2. Pertwee RG. Endocannabinoids and their pharmacological actions. Handb Exp Pharmacol. 2015;231:1–37. PubMed CrossRef
  3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. PubMed CrossRef
  4. Karimi I, Hayatghaibi H, Yousefi J, et al. The effect of Cannabis sativa L. (hemp seed) on hematological parameters in guinea pigs. Cardiovasc Hematol Disord Drug Targets. 2007;7(4):288–290. PubMed CrossRef
  5. Murikinati S, Jüttler E, Keinert T, et al. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J. 2010;24(3):788–798. PubMed CrossRef
  6. Öztürk E, Oral A, Özdemir M, et al. Synthetic marijuana “K2” induced ITP. Platelets. 2015;26(3):258–259. PubMed CrossRef
  7. Castaneira G, Rojas K, Galili Y, et al. Idiopathic thrombocytopenic purpura induced by synthetic cannabinoid. J Addict Med. 2019;13(3):235–236. PubMed CrossRef
  8. Guzel D, Yazici AB, Yazici E, et al. Alterations of the hematologic cells in synthetic cannabinoid users. J Clin Lab Anal. 2017;31(6):e22131. PubMed CrossRef
  9. Almogi-Hazan O, Khuja I, Ritter S, et al. The highs and lows of cannabis in cancer treatment and bone marrow transplantation. Rambam Maimonides Med J. 2020;11(1):e0009. PubMed CrossRef